Perspectiva Regional de la EGPA en las Américas.  Un repaso a su implementación.

Pharmaceutical Situation Caribbean 2007

Suriname Ministry of Health of Suriname. Implementing Pharmacovigilance in Suriname: 2006 – 2009. Paramaribo: PAHO/WHO and Suriname Ministry of Health, 2009.

Pharmaceutical policy:

The Pharmaceutical situation in the Americas:level 1 monitoring 2006-factbook

Technological Innovation for Chagas: Global Health Council, June 16 2010

presentation

THR/EM: Pharmaceutical Policy

Primary Health Care Pharmaceutical Services in the Americas: The Development of a Regional Position Paper and Guidelines

BID ABSTRAC HIV/AIDS 2009. Product Prices: Antiretrovirals for the Strategic Fund. Period: January 1st 2009 to December 31st 2009

Uso racional:

Program: VII Pan American Conference on Pharmaceutical Education

Regional meeting for selecting demonstration projects for innovative financing and coordination mechanisms of for research and development of health technologies. PAHO Headquarters  Washington DC 22-23 October 2013
Projects summary

 Naciones Unidas. 2009. Promoción Y Protección De Todos Los Derechos Humanos, Civiles, Políticos, Económicos, Sociales Y Culturales, Incluido El Derecho Al Desarrollo. Informe del Relator Especial sobre el derecho de toda persona al disfrute. del más alto nivel posible de salud física y mental, Sr. Anand Grover.

PROMOTION AND PROTECTION OF ALL HUMAN RIGHTS, CIVIL, POLITICAL, ECONOMIC, SOCIAL AND CULTURAL RIGHTS, INCLUDING THE RIGHT TO DEVELOPMENT

Report of the Special Rapporteur on the right of everyone to the enjoyment of the highest attainable standard of physical and mental health, Anand Grover*

Regional Perspective of the GSPA in the Americas

II Workshop on Medicines Regulation in the Caribbean Region: Presentation.

Report of the Commission on Intellectual Property Rights, Innovation and Public Health.WHO, 2006. 

Reunión de discusión sobre políticas farmacéuticas e indicadores de evaluación. Presentación de Alexandra Cameron. Department of Essential Medicines and Pharmaceutical Policies. WHO. Washington, DC. 10 y 11 de diciembre de 2009 .

Research and Development of innovative products in the Americas: a case for empowerment.

Janis K. Lazdins-Helds, M.D., Ph.D.

Neglected diseases keep on affecting scores of populations in developing countries. The lack of new and more (innovative) effective products weakens the response of national authorities and other involved stakeholders. The World Health Assembly adopted the Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property (GSPA) through resolution WHA61.21. Pan American Health Organization's (PAHO) Directing Council endorsed the regional implementation of the GSPA in the Americas through resolution CD48.15: Public Health, Innovation and Intellectual Property: A Regional Perspective.

Reunión OPS/OMS para la revisión de la regulación de vacunas y medicamentos respondiendo a la Influenza Pandémica H1N1. Diciembre de 2009, Buenos Aires

WHO H1N1 production biosafety

Reunión OPS/OMS para la revisión de la regulación de vacunas y medicamentos respondiendo a la Influenza Pandémica H1N1. Diciembre de 2009, Buenos Aires

Presentacion Cortes

 Updated August, 2013.

Presentation: Dennis Ross-Degnan. Harvard Medical School and Harvard Pilgrim Health Care Institute.

Reunión de discusión sobre políticas farmacéuticas e indicadores de evaluación. Washington, DC. 10 y 11 de diciembre del de 2009

II Workshop on Medicines Regulation in the Caribbean: Te Regulatory dimension as an Essential Public Health Function